Estrella Immunopharma Inc. (ESLA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Estrella Immunopharma Inc...

    NASDAQ: ESLA · Real-Time Price · USD
    1.20
    0.00 (0.00%)
    At close: Sep 29, 2025, 12:16 PM

    Estrella Immunopharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2022 Jun 30, 2022
    Net Income
    		 -8.85M -7.31M -996.1K -1.69M
    Depreciation & Amortization
    		 n/a n/a n/a n/a
    Stock-Based Compensation
    		 n/a 1.19M n/a 129.97K
    Other Working Capital
    		 847.78K -618.09K 576.86K 113.35K
    Other Non-Cash Items
    		 509.33K n/a -654.07K -1.43K
    Deferred Income Tax
    		 n/a n/a 29.47K n/a
    Change in Working Capital
    		 775.7K -9.95M 576.86K 113.35K
    Operating Cash Flow
    		 -7.64M -16.07M -1.04M -1.44M
    Capital Expenditures
    		 -1 -4 n/a n/a
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a -45.19M
    Sales Maturities Of Investments
    		 n/a n/a 36.17M n/a
    Other Investing Acitivies
    		 n/a 4.96M n/a n/a
    Investing Cash Flow
    		 n/a 4.96M 36.17M -45.19M
    Debt Repayment
    		 -10M n/a 498.6K n/a
    Common Stock Repurchased
    		 -568.92K -354.44K -36.11M -25K
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 9.58M 4.13M 50K 530.36K
    Financial Cash Flow
    		 -489.43K 12.79M -35.56M 5.53M
    Net Cash Flow
    		 -8.13M 1.69M -438.07K 4.09M
    Free Cash Flow
    		 -7.64M -16.07M -1.04M -1.44M

    Add to Watchlist